Adial Pharmaceuticals (ADIL) Earnings Date, Estimates & Call Transcripts → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free ADIL Stock Alerts $1.71 -0.02 (-1.16%) (As of 02:54 PM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueADIL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADIL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Adial Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.58)($0.51)($0.55)Q2 20242($0.58)($0.39)($0.49)Q3 20242($0.52)($0.39)($0.46)Q4 20242($0.52)($0.39)($0.46)FY 20248($2.20)($1.68)($1.94)Q1 20251($0.39)($0.39)($0.39)Q2 20251($0.39)($0.39)($0.39)Q3 20251($0.39)($0.39)($0.39)Q4 20251($0.39)($0.39)($0.39)FY 20254($1.56)($1.56)($1.56) Get Adial Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ADIL and its competitors with MarketBeat's FREE daily newsletter. ADIL Earnings Date and InformationAdial Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.Read More Adial Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/10/2024Estimated)------- 11/14/2023Q3 2023($1.14)($1.14)-($1.10)--8/21/2023Q2 2023($1.50)($1.33)+$0.17($3.62)--5/12/2023Q1 2023($3.50)($2.75)+$0.75($0.11)--3/30/2023Q4 2022($3.75)($2.75)+$1.00($0.11)--11/14/2022Q3 2022($4.50)($3.00)+$1.50($0.12)--8/16/2022Q2 2022($4.00)($4.00)-($0.16)-- Get the Latest News and Ratings for ADIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adial Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/16/2022Q1 2022($4.25)($3.25)+$1.00($0.13)--3/28/2022Q4 2021-($7.00)($7.00)($0.28)--11/15/2021Q3 2021($5.50)($5.50)-($0.22)--8/11/2021Q2($5.00)($6.25)($1.25)($0.25)-- 5/17/2021Q1 2021-($7.50)($7.50)($0.30)-- Adial Pharmaceuticals Earnings - Frequently Asked Questions When is Adial Pharmaceuticals's earnings date? Adial Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on ADIL's earnings history. How much profit does Adial Pharmaceuticals generate each year? Adial Pharmaceuticals (NASDAQ:ADIL) has a recorded net income of -$5.12 million. ADIL has generated -$5.72 earnings per share over the last four quarters. What is Adial Pharmaceuticals's EPS forecast for next year? Adial Pharmaceuticals's earnings are expected to decrease from ($1.66) per share to ($12.82) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CVKD Earnings PTIX Earnings TENX Earnings CLVR Earnings TRVN Earnings CANF Earnings IBIO Earnings EFTR Earnings ENVB Earnings SHPH Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:ADIL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.